IXICO (LON:IXI) Shares Down 6.6% – Time to Sell?

IXICO plc (LON:IXI – Get Free Report)’s stock price fell 6.6% during mid-day trading on Tuesday . The stock traded as low as GBX 7.47 and last traded at GBX 7.47. Approximately 120,638 shares were traded during mid-day trading, an increase of 8% from the average session volume of 111,293 shares. The stock had previously closed at GBX 8.

IXICO Stock Down 6.6%

The company has a quick ratio of 4.90, a current ratio of 2.83 and a debt-to-equity ratio of 5.22. The company has a market capitalization of £16.36 million, a P/E ratio of -3.83, a price-to-earnings-growth ratio of -0.38 and a beta of 0.13. The company has a 50-day moving average of GBX 8.37 and a two-hundred day moving average of GBX 8.24.

Get IXICO alerts:

IXICO (LON:IXI – Get Free Report) last posted its quarterly earnings data on Tuesday, May 19th. The company reported GBX (1.21) earnings per share (EPS) for the quarter. The firm had revenue of GBX 395 million during the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%. On average, research analysts predict that IXICO plc will post -289.3584879 EPS for the current year.

Insider Buying and Selling at IXICO

In other IXICO news, insider Mark Warne bought 50,006 shares of IXICO stock in a transaction dated Wednesday, July 15th. The shares were purchased at an average cost of GBX 8 per share, with a total value of £4,000.48. 3.07% of the stock is owned by corporate insiders.

IXICO Company Profile

(Get Free Report)

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.

Recommended Stories

• Five stocks we like better than IXICO
• Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
• AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
• NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
• Apple’s Next iPhone Could Test How Much Pricing Power Is Left

Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.